News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Quinn Shari L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/13/2016 |
4
| O'Quinn Shari L (VP, Clinical & Regulatory) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 21,834 shares
@ $0 |
|
| 03/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/05/2016 |
3
| O'Quinn Shari L (VP, Clinical & Regulatory) has filed a Form 3 on ENDOLOGIX INC /DE/ |
| 02/04/2016 |
4
| O'Quinn Shari L (VP Clinical/Regulatory Affairs) has filed a Form 4 on TriVascular Technologies, Inc.|
Txns:
| Paid exercise price by delivering 3,549 shares
@ $5.62, valued at
$19.9k
Disposed/sold 5,851 shares
@ $0
Paid exercise price by delivering 18,092 shares
@ $5.62, valued at
$101.7k
Disposed/sold 23,746 shares
@ $0
Exercised 9,400 restricted stock units
@ $0
Exercised 41,838 options to buy
@ $2.43, valued at
$101.7k
|
|
|
|